Back to Search Start Over

Blood Lymphocyte Subsets and Proinflammatory Cytokine Profile in ROHHAD(NET) and non-ROHHAD(NET) Obese Individuals.

Authors :
Fava, Daniela
Morandi, Fabio
Prigione, Ignazia
Angelelli, Alessia
Bocca, Paola
Pistorio, Angela
Volpi, Stefano
Patti, Giuseppa
Pepino, Carlotta
Casalini, Emilio
Allegri, Anna Elsa Maria
Iorgi, Natascia Di
d'Annunzio, Giuseppe
Napoli, Flavia
Maghnie, Mohamad
Source :
Journal of the Endocrine Society; Sep2023, Vol. 7 Issue 9, p1-12, 12p
Publication Year :
2023

Abstract

Context Rapid-onset obesity with central hypoventilation, hypothalamic dysfunction, and autonomic dysregulation with neural crest tumors (ROHHAD-NET) syndrome pathophysiology remains elusive. Acquired neuroimmunological dysfunction has been proposed as a possible pathogenetic pathway. Objective The aim of our study was to characterize lymphocyte subpopulations subsets in peripheral blood (PB) and to evaluate a panel of proinflammatory cytokines/chemokines in ROHHAD(NET) patients vs controls. Methods We included 11 ROHHAD(NET) patients, 7 ROHHAD and 4 ROHHAD-NET, selected by clinical criteria. Controls were 11 simple obese children, matched for age and sex. Flow cytometric analysis and enzyme-linked immunosorbent assay were performed on PB and serum samples of the 2 groups. Results Analysis revealed that T lymphocytes are significantly increased in ROHHAD(NET) patients (P =.04) with a prevalence of CD4-T cells (P =.03) and a lower number of activated CD8-T cells (P =.02). With regard to regulatory subset, patients displayed increased regulatory B cells (P =.05) and type-1 regulatory T cells (P =.03). With regard to CD8-T cells, a lower number of T effector memory was observed (P =.02). In contrast, among CD4-T cells, we found a higher number of T naive (P =.04) and T effector (P =.0008). Interleukin-8 (IL-8) levels and monocyte chemotactic protein-1 were increased in patients vs controls (P =.008 and P =.01, respectively). Furthermore, IL-8 levels were higher in the subgroup with neural tumor (P =.0058) (ROHHAD-NET) than in patients without neural tumor (ROHHAD). Soluble HLA-G was significantly lower in patients vs controls (P =.03). Conclusion Our findings contribute to support the hypothesis of immune dysregulation, which may underlie this complex, often fatal disease. Because ROHHAD(NET) syndrome is an ultra-rare disease, multicentric studies are needed to improve the effect of our data in the management of this condition. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
24721972
Volume :
7
Issue :
9
Database :
Complementary Index
Journal :
Journal of the Endocrine Society
Publication Type :
Academic Journal
Accession number :
170902998
Full Text :
https://doi.org/10.1210/jendso/bvad103